Correlation Between Ensign and Tandem Diabetes

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ensign and Tandem Diabetes at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ensign and Tandem Diabetes into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between The Ensign Group and Tandem Diabetes Care, you can compare the effects of market volatilities on Ensign and Tandem Diabetes and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ensign with a short position of Tandem Diabetes. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ensign and Tandem Diabetes.

Diversification Opportunities for Ensign and Tandem Diabetes

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Ensign and Tandem is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding The Ensign Group and Tandem Diabetes Care in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tandem Diabetes Care and Ensign is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on The Ensign Group are associated (or correlated) with Tandem Diabetes. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tandem Diabetes Care has no effect on the direction of Ensign i.e., Ensign and Tandem Diabetes go up and down completely randomly.

Pair Corralation between Ensign and Tandem Diabetes

Given the investment horizon of 90 days The Ensign Group is expected to under-perform the Tandem Diabetes. But the stock apears to be less risky and, when comparing its historical volatility, The Ensign Group is 3.38 times less risky than Tandem Diabetes. The stock trades about -0.13 of its potential returns per unit of risk. The Tandem Diabetes Care is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  2,787  in Tandem Diabetes Care on October 20, 2024 and sell it today you would earn a total of  728.00  from holding Tandem Diabetes Care or generate 26.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

The Ensign Group  vs.  Tandem Diabetes Care

 Performance 
       Timeline  
Ensign Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days The Ensign Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
Tandem Diabetes Care 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Tandem Diabetes Care are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, Tandem Diabetes may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Ensign and Tandem Diabetes Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ensign and Tandem Diabetes

The main advantage of trading using opposite Ensign and Tandem Diabetes positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ensign position performs unexpectedly, Tandem Diabetes can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tandem Diabetes will offset losses from the drop in Tandem Diabetes' long position.
The idea behind The Ensign Group and Tandem Diabetes Care pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Bonds Directory
Find actively traded corporate debentures issued by US companies
Volatility Analysis
Get historical volatility and risk analysis based on latest market data